Wang Wei, Hao Li-Ping, Song Haizhu, Chu Xiao-Yuan, Wang Rui
Department of Medical Oncology, Jinling Hospital, Nanjing Medical University, Nanjing, China.
Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.
Front Oncol. 2022 Feb 24;12:790916. doi: 10.3389/fonc.2022.790916. eCollection 2022.
Hepatocellular carcinoma (HCC) is the sixth highest-incidence cancer and the 4th most deadly cancer all over the world, with a high fatality and low diagnostic rate. Nowadays, Excessive alcohol consumption, type-2 diabetes, smoking and obesity have become some primary risk factors of HCC. As intercellular messenger transporting information cargoes between cells, exosomes are a type of extracellular vesicles (EVs) released by most types of cells including tumor cells and non-tumor cells and play a pivotal role in establishing an HCC microenvironment. Exosomes, and more generally EVs, contain different molecules, including messenger RNAs (mRNAs), non-coding RNAs (ncRNAs), proteins, lipids and transcription factors. The three main ncRNAs in exosomes are microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs). NcRNAs, identified as essential components, are selectively sorted into exosomes and exosomal ncRNAs show great potential in regulating tumor development, including proliferation, invasion, angiogenesis, metastasis, immune escape and drug resistance. Here, we chiefly review the formation and uptake of exosomes, classification of exosomal ncRNAs and current research on the roles of exosomal ncRNAs in HCC progression. We also explored their clinical applications as new diagnostic biomarkers and therapeutic avenues in HCC.
肝细胞癌(HCC)是全球发病率第六高、致死率第四高的癌症,其致死率高且诊断率低。如今,过量饮酒、2型糖尿病、吸烟和肥胖已成为HCC的一些主要危险因素。作为在细胞间传递信息货物的细胞间信使,外泌体是包括肿瘤细胞和非肿瘤细胞在内的大多数类型细胞释放的一种细胞外囊泡(EVs),在建立HCC微环境中起关键作用。外泌体,更普遍地说是EVs,包含不同的分子,包括信使核糖核酸(mRNAs)、非编码核糖核酸(ncRNAs)、蛋白质、脂质和转录因子。外泌体中的三种主要ncRNAs是微小核糖核酸(miRNAs)、长链非编码核糖核酸(lncRNAs)、环状核糖核酸(circRNAs)。NcRNAs被确定为重要组成部分,被选择性地分选到外泌体中,外泌体ncRNAs在调节肿瘤发展方面显示出巨大潜力,包括增殖、侵袭、血管生成、转移、免疫逃逸和耐药性。在此,我们主要综述外泌体的形成与摄取、外泌体ncRNAs的分类以及外泌体ncRNAs在HCC进展中作用的当前研究。我们还探讨了它们作为HCC新诊断生物标志物和治疗途径的临床应用。
Front Oncol. 2022-2-24
Cell Mol Life Sci. 2019-7-12
Curr Oncol. 2022-7-29
Cancers (Basel). 2024-4-4
Biochem Biophys Rep. 2024-3-24
Onco Targets Ther. 2021-1-12
Cancers (Basel). 2025-3-10
Cancers (Basel). 2024-4-4
Front Bioeng Biotechnol. 2023-6-29
Appl Biochem Biotechnol. 2024-3
J Clin Transl Hepatol. 2023-6-28
Sci China Life Sci. 2023-2
J Clin Lab Anal. 2021-11
Biomark Med. 2021-4
Aging (Albany NY). 2020-12-26
J Cell Mol Med. 2021-1